Publishing Conference Papers

Publishers and professional scientists enjoy a love-hate relationship over volumes of conference proceedings. Many researchers question whether science is well served by conference papers published as collections in journals or books. Reviewers frequently criticize proceedings books for their high prices and poor physical appearance, for a lack of rigorous editing, or for long publication delays. Some academic publishers must share this skepticism because they rarely produce books arising from m

Written bySimon Mitton
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Clearly there are good and bad books of this type. The success of such a venture depends in part on how one approaches the question of whether or not to attempt publication of the papers presented at a meeting and on how the papers are handled.

Publication and the issues it raises need to be considered early in the planning of a scientific meeting. Quite often the sponsors of a meeting will insist on publication, and there may already be a standing arrangement with a publisher. If there are no prior commitments there are several important reasons to act decisively. For example, some keynote speakers may not want the chore of writing yet another version of their famous lectures. When you approach them, they might ask if you insist on publication, and perhaps be reluctant to participate if you do. Researchers with major new results may not want their data ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies